Advertisement
Afrezza Coupon - Afrezza 90 cartridges of 4 units kit
Afrezza (insulin) is a moderately priced drug used to treat diabetes mellitus, including diabetes type 1 and diabetes type 2. This drug is less popular than comparable drugs. There are currently no generic options for any insulin brand, but less expensive biosimilar versions may be available in the future. It is not covered by most Medicare and insurance plans, but manufacturer and pharmacy coupons can help offset the cost. Compare insulins.
Advertisement

Afrezza Latest News

Get the latest updates on this drug from the GoodRx medical team

This Class of Drugs Causes Almost 100,000 Annual Emergency Visits

Dr. Sharon Orrange - June 07, 2016

Insulin: legal, widely used, and transforms lives. But there are risks—soon you’ll see why we try to spare our type II diabetics from having to start insulin. Using oral medications to their maximum dose and incorporating diet and lifestyle changes is the way to go before resorting to insulin.

Of course, tight blood sugar control is the goal for reducing diabetes related complications (kidney disease, eye disease, neuropathy) but insulin remains one of the most challenging aspects of diabetes management given the risks. See More

FDA Approval: First New Long-Acting Insulins in 10 Years

The GoodRx Pharmacist - October 23, 2015

There have been several new insulin products approved over the past year, including Toujeo, Humalog U-200, Afrezza—and now Tresiba and Ryzodeg.

The other recent insulin approvals are what I like to call spin-off insulin products. For example, Toujeo has the same type of insulin as Lantus (insulin glargine), but is more concentrated. Humalog U-200 is the same exact product as Humalog U-100 (insulin lispro), but once again, more concentrated. See More

Afrezza: The New Inhaled Insulin

The GoodRx Pharmacist - April 21, 2015

Several years ago when I was first starting out as an intern in the retail pharmacy setting, Exubera, an inhaled insulin, was collecting dust on our shelf.

The idea of inhaled insulin sounded great, especially for people who had a phobia of using needles for injection. A few years back there weren’t even as many insulin pen options as there are now, yet Exubera failed and was discontinued.

Despite the failure of Exubera back in October of 2007, a new inhaled insulin, Afrezza, has been FDA approved and is now on the market. See More

Inhaled Insulin: Ten Things You Need to Know

Dr. Sharon Orrange - July 01, 2014

The FDA just approved Afrezza, an inhaled insulin for both Type 1 and Type 2 diabetics. It will be available for prescription very soon, so will there be a run on it? Here are ten points to keep in mind.

  1.  The product will be called Afrezza and was developed by the MannKind Corporation.

  2.  It’s not the first time we’ve heard about inhaled insulin. Exubera, Pfizer’s attempt at inhaled insulin, was never popular because of a possible increase in lung cancer. See More

GoodRx is not sponsored by or affiliated with any of the pharmacies identified in its price comparisons. All trademarks, brands, logos and copyright images are property of their respective owners and rights holders and are used solely to represent the products of these rights holders. This information is for informational purposes only and is not meant to be a substitute for professional medical advice, diagnosis or treatment. GoodRx is not offering advice, recommending or endorsing any specific prescription drug, pharmacy or other information on the site. GoodRx provides no warranty for any of the pricing data or other information. Please seek medical advice before starting, changing or terminating any medical treatment.